FindTrial
Sign In

Accuracy of staging with integrated PET-CT and EUS-FNA and or EBUS-TBNA in patients with operable non-small cell lung cancer

Accuracy of staging with integrated PET-CT and EUS-FNA and or EBUS-TBNA in patients with operable non-small cell lung cancer - E(B)US vs lymph node dissection

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON32147
Enrollment
100
Registered
2008-02-07
Start date
2008-05-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lungcancer NSCLC

Interventions

All patients will undergo PET-CT and EUS-FNA and / or EBUS-TBNA. Patients with tumor-negative mediastinum will undergo a thoracotomy with mediastinal lymph node dissection

Sponsors

Isala Klinieken
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1.Patients with operable NCSLC. 2.age of 18-85 years.

Exclusion criteria

Exclusion criteria: 1.comorbidity (alcoholabuse, drugsabuse and psychiatric disease limiting decision making) 2.non-compliance 3.previous randomisation in this study

Design outcomes

Primary

MeasureTime frame
Accuracy of PET-CT and E(B)US in staging NSCLC compared with mediastinal lymphe node dissection—

Secondary

MeasureTime frame
Accuracy of PET-CT and E(B)US in locating controlateral tumor-positive lymph nodes compared to mediastinal lymph node dissection—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)